Senators Blast DTC Platforms Launched By Pharma Giants With Telehealth Companies

By Christian Robles / July 17, 2025 at 1:47 PM

A group of three Democratic senators and one independent senator are blasting direct-to-consumer platforms that pharmaceutical giants Pfizer and Lilly paid telehealth companies to help launch, alleging the partnerships have led to over-prescribing that hiked health care spending, left patients with sub-standard care, eroded patient-physician relationships and pose potential conflicts of interest.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.